📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey. (2021)

First Author: Hüls A

Attributed to: Neuropathological and amyloid peptide differences between DS and familial AD with duplications and missense mutations in APP gene funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2021.100769

PubMed Identifier: 33644721

Publication URI: http://europepmc.org/abstract/MED/33644721

Type: Journal Article/Review

Volume: 33

Parent Publication: EClinicalMedicine

ISSN: 2589-5370